Massachusetts General Hospital/Harvard Medical School
Postdoctoral Fellow - Neuroimaging
Center for Addiction Medicine – Boston, MA
Postdoctoral researcher needed at the Center for Addiction Medicine in the Department of Psychiatry at Massachusetts General Hospital/Harvard Medical School to participate in research involving neuroimaging (fNIRS) of models of acute cannabis intoxication. Multi-disciplinary approaches include, but are not limited to behavioral assessments, neuroimaging, and pharmacological modeling. In addition to hands-on conduct of experiments and neuroimaging acquisition and analysis, duties will also include manuscript preparation, presentation of findings at conferences, and management of research assistants. Fellow will participate actively in ongoing research and grant submissions, will complete pilot projects, have opportunities for publications and presentations using new and existing datasets, and will have an opportunity to prepare independent research grants.
Massachusetts General Hospital/ Harvard Medical School offers an excellent environment to engage in multidisciplinary research through various collaborative opportunities. Laboratory resources include research-dedicated 3T and 7T MRI scanners, and fNIRS/EEG devices. For more information, visit our website: http://www.mghaddictionmedicine.com/
Contact: Jodi Gilman (firstname.lastname@example.org)
Candidates should have a PhD/MD or equivalent degree. Qualified applicants should have track record of first-author research papers published in peer-reviewed journals. We are looking for highly motivated, self-driven, creative, and interactive scientists. Excellent verbal and written communication skills are required as well as an interest in or prior experience in fNIRS neuroimaging. Experience in conducting behavioral studies is welcome.
Internal Number: 320
About Massachusetts General Hospital Center for Addiction Medicine
Since its formation in 2005, the center has employed psychiatrists, neuroscientists, psychologists, neuropsychologists and computer scientists who have conducted clinical and translational research that have resulted in new treatments for addictive disorders and extended the application of existing treatments as well as major work to reduce the stigma of addictive disorders.
The Center provides opportunities for post doctoral candidates with PhD’s in neuroscience, psychology or neuropsychology or physicians with psychiatry residency training. We seek highly motivated individuals for mentored work in the area of patient-oriented clinical or translational addiction research. Prior fellows from the Center have been highly successful in producing influential scholarly work, obtaining prestigious grant funding, and academic positions within Harvard or elsewhere after they complete the fellowship. We also train the next generation of clinician scientists though an ACGME approved clinical addiction psychiatry fellowship for physicians who have completed a psychiatry residency and wish to attain additional training and become board eligible in addiction psychiatry.
We have been among... the first to test novel pharmacotherapies for addictive disorders such as acetylcholinesterase inhibitors, dopamine D3 agonists, glycine antagonists and reuptake inhibitors, cognitive enhancing agents, mindfulness training, and real time fMRI neurofeedback for addictive disorders. Our clinical trials established the knowledge base for the first clinical practice guidelines for nicotine dependence treatment for people with serious mental illness. Our scientists are working to understand the most effective components of 12-step facilitation groups such as alcoholics anonymous and whether this approach is an effective one for teens.
Among the many ongoing translational studies at the center is a trail to evaluate evaluate cognitive control training over brain regions related to craving and inhibitory control with real time fMRI neurofeedback. Other studies evaluate both brain and behavioral responses to rewards in the environment, to social influence on impulsive decision-making, and to risk taking. Another line of studies is investigating the similarities in neural response to drug or food cues among those with nicotine dependence and obesity, and their predictive value in smoking cessation and bariatric surgery outcomes. Researchers at the center have demonstrated that brain activation to smoking cues is highly predictive of smoking cessation outcomes one month later.